Home Latin News Dexamethasone, solely therapeutic efficient in opposition to Covid-19, WHO chief states — Autopresse.eu

Dexamethasone, solely therapeutic efficient in opposition to Covid-19, WHO chief states — Autopresse.eu

Dexamethasone, solely therapeutic efficient in opposition to Covid-19, WHO chief states — Autopresse.eu

Dexamethasone, solely therapeutic efficient in opposition to Covid-19, WHO chief states — Autopresse.eu

2020-10-17 08:42:00

Dexamethasone, solely therapeutic efficient in opposition to Covid-19, WHO chief states

Saturday, October seventeenth 2020 – 08:42 UTC


“For the second, the corticosteroid dexamethasone continues to be the one therapeutic proven to be efficient in opposition to COVID-19, for sufferers with extreme illness,” Tedros.

At present, the drug dexamethasone continues to be the one therapeutic proven to be efficient in opposition to the novel coronavirus for extreme sufferers, the chief of the World Well being Group mentioned Friday.

At present, the drug dexamethasone continues to be the one therapeutic proven to be efficient in opposition to the novel coronavirus for extreme sufferers, the chief of the World Well being Group mentioned Friday.

WHO Director-Normal Tedros Ghebreyesus addressed journalists at a twice-weekly webinar from Geneva on the combat in opposition to the pandemic.

He revealed interim outcomes from the WHO’s Solidarity Therapeutics Trial and referred to influenza, which might be countered utilizing a number of the identical strategies as these used in opposition to COVID-19.

Tedros additionally cautioned that demand for influenza vaccines may outstrip provide in some international locations, notably within the northern hemisphere, as Winter arrives.

“The Strategic Advisory Group of Specialists on Immunization has subsequently really useful that, among the many 5 threat teams, well being staff and older adults are the very best precedence teams for influenza vaccination in the course of the COVID-19 pandemic,” he mentioned.

“Yearly, there are as much as 3.5 million extreme instances of seasonal influenza worldwide, and as much as 650,000 respiratory-related deaths.”

Throughout this yr’s southern hemisphere winter, the variety of seasonal flu instances and deaths was lower than typical because of the measures taken to comprise COVID-19.

“However, we can’t assume the identical might be true within the northern hemisphere flu season,” mentioned the WHO chief.

Turning to the Solidarity Therapeutics Trial, Tedros mentioned it confirmed that two different medicine, remdesivir and interferon, have little or no impact on stopping coronavirus-related deaths or lowering time within the hospital.

“For the second, the corticosteroid dexamethasone continues to be the one therapeutic proven to be efficient in opposition to COVID-19, for sufferers with extreme illness,” mentioned Tedros.

Dexamerhasone is used within the therapy of many situations, together with rheumatic difficulty, varied pores and skin situations, extreme allergy symptoms, bronchial asthma, persistent obstructive lung illness, croup, mind swelling and eye ache following eye surgical procedure. Additionally it is used with antibiotics in instances of tuberculosis.

The COVID-19 pandemic has claimed greater than 1.1 million lives in 188 international locations and areas since final December. The US, India, Brazil, and Russia are at present the worst-hit international locations.

Greater than 39 million instances have been reported worldwide, whereas practically 27 million sufferers have recovered, in accordance with figures compiled by the US’ Johns Hopkins College.

Leave a Reply

Your email address will not be published.